Doctor Details

Biosketch

Dr Mayank Dalakoti completed his Bachelor's in Medicine and Surgery (MBBS) from The National University of Singapore in 2013. During medical school, he was President of The National University of Singapore Medical Society from 2011-2012. He receieved a nomination on the Dean's list and multiple awards such as the NUS Society Gold Medal and The Medical Society All-Round excellence award in 2013. He went on to complete his Masters in Medicine (MMed) from The National University of Singapore and attained Membership of The Royal College of Physicians (MRCP), United Kingdom, in 2017. He completed his training in Internal Medicine at The National University Hospital in 2017, followed by Cardiology in 2022. He was awarded Valedictorian of the NUH Residency Program in 2022.

Dr Mayank's focus within cardiology is in prevention and cardiometabolic medicine. As a committee member of the NUHS health district, he also works with primary care partners, public health specialists and regional health services to understand the social determinants of the population's health. This also involves work in digital healthcare, using information gathered from wearables to assist with cardiovascular disease risk stratification and interventions.

His research is in the identification of predictive biomarkers of early clinical cardiometabolic disease, with the aim of early therapeutic interventions, as well as health services research focusing on the implementation of novel digital-enabled population-level health interventions at scale. He is the PI of the Platform for Interdisciplinary Cardiovascular-Metabolic Collaboration in NUHS (PICMAN) together with Prof Roger Foo. This is an ongoing preventative cardiology cohort in collaboration with the EMULSION cohort of patients with fatty liver disease (PI Prof Dan YY and Mark Muttiah) targeting predictive biomarkers and tools to further risk stratify an individuals' cardiovascular disease risk. He is also clinical PI of the LIVE-PLUS randomized controlled trial together with the University of Sydney, to study the effect of a composite of digital health interventions targeting diet, exercise, mindfulness and stress reduction on the cardiovascular and metabolic profile of patients. Dr Mayank is also a member of the Heart-Brain Research Collaboration in NUHS, and is PI of the Atrial Cardiopathy Evaluation in Embolic Stroke of Unknown Source (ACE-ESUS) study assessing novel imaging modalities for patients with cryptogenic stroke.